Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11301
PUT
Build-A-Bear
BBW
$315M
| $82.5K | ﹤0.01% |
2,400
-36,900
| -94% | -$1.04M |
2021 Q1
14 quarters
|
|
11302
CALL
Invesco Dorsey Wright Technology Momentum ETF
PTF
$634M
| $82.5K | ﹤0.01% |
+1,300
| New | +$79.2K |
2024 Q3
0 quarters
|
|
11303
CALL
American Resources Corp
AREC
$174M
| $82.4K | ﹤0.01% |
90,600
+12,700
| +16% | +$7.65K |
2021 Q2
13 quarters
|
|
11304
AC Immune
ACIU
$256M
| $82.4K | ﹤0.01% |
21,806
-13,002
| -37% | -$45.4K |
2024 Q1
2 quarters
|
|
|
CHX
11305
DELISTED
ChampionX
CHX
| $82.3K | ﹤0.01% |
2,729
-447,562
| -99% | -$14.1M |
2022 Q4
7 quarters
|
|
11306
Mind CTI
MNDO
$19.6M
| $82K | ﹤0.01% |
41,413
+14,988
| +57% | +$28.4K |
2022 Q3
8 quarters
|
|
11307
CALL
Ingevity
NGVT
$2.44B
| $81.9K | ﹤0.01% |
2,100
-4,100
| -66% | -$163K |
2020 Q1
18 quarters
|
|
11308
CALL
Sotera Health
SHC
$5.11B
| $81.8K | ﹤0.01% |
4,900
-3,200
| -40% | -$46.7K |
2021 Q3
12 quarters
|
|
11309
Microvision
MVIS
$46.5M
| $81.8K | ﹤0.01% |
4,781
+1,376
| +40% | +$21.4K |
2024 Q2
1 quarter
|
|
11310
PUT
GrowGeneration
GRWG
$90.1M
| $81.6K | ﹤0.01% |
38,300
+3,900
| +11% | +$8.36K |
2020 Q3
16 quarters
|
|
11311
PUT
Entrada Therapeutics
TRDA
$218M
| $81.5K | ﹤0.01% |
+5,100
| New | +$80.4K |
2024 Q3
0 quarters
|
|
11312
CALL
State Street SPDR S&P Health Care Equipment ETF
XHE
$179M
| $81.5K | ﹤0.01% |
900
+600
| +200% | +$52.2K |
2022 Q4
7 quarters
|
|
11313
SU Group Holdings
SUGP
$706K
| $81.4K | ﹤0.01% |
+198
| New | +$125K |
2024 Q3
0 quarters
|
|
11314
CALL
Inovio Pharmaceuticals
INO
$120M
| $81.4K | ﹤0.01% |
14,080
-1,560
| -10% | -$12.9K |
2019 Q4
19 quarters
|
|
|
HTO
11315
PUT
H2O America
HTO
$2.43B
| $81.4K | ﹤0.01% |
1,400
-3,900
| -74% | -$228K |
2023 Q4
3 quarters
|
|
|
PBK
11316
PowerBank Corp
PBK
$15.6M
| $81.3K | ﹤0.01% |
18,278
-6,678
| -27% | -$31.9K |
2024 Q2
1 quarter
|
|
11317
Steris
STE
$20.4B
| $81.3K | ﹤0.01% |
335
-219,166
| -100% | -$51.3M |
2024 Q2
1 quarter
|
|
11318
PUT
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.46B
| $81.2K | ﹤0.01% |
900
+500
| +125% | +$44.1K |
2022 Q4
7 quarters
|
|
11319
CALL
Stoke Therapeutics
STOK
$1.57B
| $81.1K | ﹤0.01% |
6,600
-4,700
| -42% | -$66.6K |
2022 Q4
7 quarters
|
|
11320
PUT
Supernus Pharmaceuticals
SUPN
$2.51B
| $81.1K | ﹤0.01% |
2,600
-2,600
| -50% | -$81.1K |
2022 Q4
7 quarters
|
|
11321
CALL
KLX Energy Services
KLXE
$27.8M
| $81K | ﹤0.01% |
14,800
+10,600
| +252% | +$64.2K |
2022 Q3
8 quarters
|
|
11322
CALL
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.01B
| $80.8K | ﹤0.01% |
1,400
-8,400
| -86% | -$473K |
2023 Q4
3 quarters
|
|
|
LAR
11323
PUT
Lithium Argentina AG
LAR
$881M
| $80.8K | ﹤0.01% |
24,800
-7,500
| -23% | -$20.8K |
2023 Q4
3 quarters
|
|
11324
CALL
Precigen
PGEN
$2.7B
| $80.8K | ﹤0.01% |
85,300
+7,100
| +9% | +$8.96K |
2013 Q3
44 quarters
|
|
|
PHLT
11325
PUT
DELISTED
Performant Healthcare Inc
PHLT
| $80.8K | ﹤0.01% |
+21,600
| New | +$73.8K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.